Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cranberry for Dysbiosis in Crohn's Disease
NCT07170462Phase 1Completed
- Start
- Oct 2025
- Primary completion
- Aug 2026
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial in Crohn's disease (2 arms). Primary endpoint: Change in relative abundance of butyrate-producing Clostridia species at 15 weeks. Started Oct 2025; status: completed.
02
Conditions
Crohn's disease
Beyond the preview
Go deeper on NCT07170462.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07170462.